Innovative nanotools for vascular drug delivery: the atherosclerosis case study

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Cardiovascular Research

Background:

• Cardiovascular diseases, particularly atherosclerosis, are a leading cause of mortality globally.
• Modern lifestyles (sedentary habits, high-fat diets, smoking) contribute to the high prevalence of atherosclerosis.
• Current non-specific treatments for vascular pathologies have limitations including poor biodistribution, rapid elimination, and side effects.

Purpose of the Study:

• To critically analyze recent advancements in nanotechnology for atherosclerosis therapy and diagnosis.
• To explore innovative nanotechnological approaches to overcome limitations of current treatments.
• To provide an overview of the potential of nanotechnology in managing vascular pathologies.

Main Methods:

• Literature review of recent publications on nanotechnology in atherosclerosis.
• Critical analysis of reported results regarding diagnostic and therapeutic nanotechnologies.
• Synthesis of information on novel nanomedical strategies.

Main Results:

• Nanotechnology presents significant potential for targeted therapy and improved diagnosis of atherosclerosis.
• Emerging nanotechnologies show promise in enhancing drug delivery and reducing side effects.
• Innovative approaches are being developed to improve biodistribution and efficacy of treatments.

Conclusions:

• Nanotechnology is a rapidly advancing field with great potential to revolutionize atherosclerosis management.
• Further research and development in nanomedicine are crucial for clinical translation.
• Nanotechnology-based strategies offer a promising future for treating vascular pathologies.